Knowledge base · Peer-reviewed

ScaleWiki.

Peer-reviewed manuscripts on the G-Rex® platform — one citable page per paper, curated so you find the evidence that moves your cell & gene therapy program forward.

487Manuscripts indexed
14Cell types
Live indexContinuously updated

Showing 12 of 530 resources

Publications Other G-Rex®6 Well Plate, G-Rex®6M Well Plate

Publication Date: July 4, 2020

A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture

A two-step serum-free culture in gas-permeable G-Rex® devices expanded cytokine-induced killer (CIK) cells far more than conventional T-flasks. Donor peripheral blood mononuclear cells were stimulated with IFN-γ, CD3 and IL-2, seeded in G-Rex®6 plates and moved to G-Rex®6M after 7 days (G-Rex®6–6M protocol), reaching a 752-fold increase from 2.5 × 10^6 cells. G-Rex®6M alone gave a 124-fold increase in X-VIVO, against 2.3-fold in X-VIVO T-flasks and 8.4-fold in RPMI with fetal bovine serum. Cultures were counted at days 7, 14, 21 and 28. G-Rex®6–6M cells kept better long-term viability and expressed more CD27 and CCR7 than T-flask cells. Cytotoxicity against K562, Raji and MDA-MB-468 targe…

Download Now →

Author: Pierangela Palmerini, Anna Dalla Pietà +10 more

Publications CAR T Cells G-Rex®6 Well Plate

Publication Date: June 30, 2020

The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing

Five lentiviral CD123-specific CAR constructs, each co-expressing CD20 as a safety switch, were compared head to head to choose one for clinical testing in acute myeloid leukemia, and the CAR with a CD28 hinge/transmembrane domain and CD28z signaling (28.28z) was selected. Transduced T cells from healthy donors expanded more than 50-fold in 7 days with viability above 80%, and all constructs killed CD123-positive Molm13 cells in vitro. The 8.41BBz construct showed baseline interferon-γ release, mice given the 716-based CAR had lower survival at 3 × 10^6 cells, and adding 41BB to CD28 gave no benefit. The 28.28z CAR was chosen for its higher surface expression, a mean 2.3-fold higher MFI t…

Download Now →

Author: Janice M. Riberdy, Sheng Zhou +11 more

Publications NK Cells G-Rex®6 Well Plate

Publication Date: June 24, 2020

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways

A B-lymphoblastoid 721.221 feeder cell line engineered to display membrane-bound IL-21 expanded human NK and CD19 CAR-NK cells better than the conventional K562-based equivalent. Peripheral blood mononuclear cells were stimulated with irradiated feeder cells plus IL-2 and IL-15 for 21 days; across 11 donors the 221-mIL-21 feeders gave higher fold expansion and NK purity than K562-mIL-21, with reported averages of 39,663-fold versus 3,588-fold. Cord blood NK cells expanded more on 221-mIL-21 feeders, and CD19-CAR-NK cells expanded on them killed Raji and Daudi targets better in vitro and in mouse lymphoma models. RNA sequencing linked the superior expansion to upregulated amino acid metabo…

Download Now →

Author: Yan Yang, Saiaditya Badeti +6 more

Publications T-Cells, Treg Cells

Publication Date: June 24, 2020

Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis

Combining targeted single-cell RNA sequencing of 397 genes with oligo-conjugated antibodies revealed that the co-stimulatory molecules CD80 and CD86, normally found on antigen-presenting cells, mark a subset of recently activated regulatory T cells in human blood. The approach profiled 43,656 CD4+ T cells and 31,907 CD45+ cells from blood and duodenal biopsies, using up to 68 protein targets. Flow cytometry in four healthy donors confirmed B7 expression mainly on memory Tregs, and in vitro IL-2 alone induced and sustained it. Targeted sequencing detected FOXP3 in 68.3% of Tregs versus 23.2% and 18.3% in whole-transcriptome datasets, and mean mRNA-protein correlation in resting CD4+ T cell…

Download Now →

Author: Dominik Trzupek, Melanie Dunstan +11 more

Publications T-Cells

Publication Date: June 22, 2020

Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity

Ex vivo photodepletion of alloprimed donor splenocytes with the photosensitizer 2-Se-Cl prevented lethal graft-versus-host disease while keeping antileukemic activity in a fully MHC-mismatched mouse transplant model. BALB/c recipients given T cell-depleted bone marrow, A20 leukemia cells and 5 × 10^6 photodepleted cells survived beyond 100 days with no GVHD or leukemia. Mice given no T cells died of leukemia at a mean of 21 days, and those given untreated primed splenocytes died of GVHD at a mean of 25 days. Post-transplant cyclophosphamide did not prevent lethal GVHD (mean 37 days). Flow cytometry 15 days after transplant linked GVHD to exhausted T cells and long-term survival to polyfun…

Download Now →

Author: Jason M. Grayson, Mildred D. Perez +4 more

Publications CAR T Cells G-Rex®24 Well Plate

Publication Date: June 19, 2020

Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery

Allogeneic FLT3 CAR T cells with a rituximab-responsive off-switch showed strong activity against acute myeloid leukemia in preclinical models, and depleting them after leukemia clearance allowed bone marrow recovery in mice. A fully human scFv, P3E10, was chosen as the lead CAR. TALEN-mediated disruption of TRAC and CD52 did not change antitumor activity, and edited cells resisted anti-CD52 antibody. The cells eliminated more than 80% of primary AML blasts in 48 h at a 1:1 ratio. They also killed human and mouse hematopoietic progenitors, and four of five mice given rituximab regained progenitor levels seen in naive mice without leukemia relapse.

Download Now →

Author: Cesar Sommer, Hsin-Yuan Cheng +10 more

Publications CAR T Cells

Publication Date: May 26, 2020

Direct Delivery of piggyBac CD19 CAR T Cells Has Potent Anti-tumor Activity against ALL Cells in CNS in a Xenograft Mouse Model

Delivering piggyBac CD19 CAR T cells directly into the cerebroventricular space cleared acute lymphoblastic leukemia from the central nervous system of every treated mouse, while intravenous delivery gave only a partial effect. Researchers injected 2 × 10^5 SU/SR ALL cells into the lateral ventricle of NOG mice and, seven days later, gave 2 × 10^6 CAR T cells either intravenously (n = 7) or intracerebroventricularly (n = 8). All CAR T-treated mice were alive at day 45, but three of five in the intravenous group had residual disease. Some i.c.v. mice showed transient clinical changes within a few days, yet none had neurological symptoms or fatal adverse events, and serum and cerebrospinal…

Download Now →

Author: Kuniaki Tanaka, Itaru Kato +10 more

Publications CTL Cells

Publication Date: May 8, 2020

Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity

Fusing attenuated interleukin-21 (IL-21) variants to an anti-PD-1 antibody delivers the cytokine to PD-1-expressing T cells and improves CD8+ T cell function beyond PD-1 blockade alone. Structure-guided engineering produced 101 single-substitution muteins, followed by double muteins whose KD for IL-21R exceeded 300 nM, with STAT3 activation strongly attenuated in cells lacking PD-1. In cultures of CMV-specific cytotoxic T cells primed with the fusion protein, cytotoxicity and IFN-gamma production exceeded those with anti-PD-1 antibody or no treatment. The R9E:R76A monomer fusion showed substantially improved pharmacokinetics over the first-generation R76E mutein in cynomolgus monkeys and,…

Download Now →

Author: Shanling Shen, Gail Sckisel +14 more

Publications VST Cells

Publication Date: May 8, 2020

Identification of protective T-cell antigens for smallpox vaccines

CD8+ T cells specific for E3L, an immediate early vaccinia virus protein, kill infected cells and stop infectious virus from spreading in culture, unlike T cells against the other vaccinia antigens tested. Using blood from vaccinated healthy donors, E3L-specific T cells expanded from 7 of 12 donors. Two epitopes were mapped: a CD8 epitope restricted by HLA-B35 and a CD4 epitope restricted by HLA-DR15. Only E3L-specific CD8+ T cells reduced virus titers, by 5 logs, whereas E3L-specific CD4+ T cells and CD8+ T cells against C7L, A10L or B22R did not. The CD8 epitope is shared with monkeypox, and the variola homolog, which differs by one amino acid, was still recognized by vaccinia-specific…

Download Now →

Author: Jun Ando, Minhtran C. Ngo +3 more

Publications CAR T Cells, γδ T

Publication Date: May 4, 2020

Electroporation of NKG2D RNA CAR Improves Vg9Vd2 T Cell Responses against Human Solid Tumor Xenografts

Electroporating Vγ9Vδ2 T cells with mRNA for a first-generation NKG2D-based CAR strengthened their killing of NKG2D ligand-positive solid tumor cells and prolonged survival in mouse xenograft models. The expanded cells, electroporated with CAR mRNA, lysed HepG2, MCF7, CAOV3 and Detroit562 lines, while NKG2D ligand-negative A549 cells stayed resistant. Cells cryopreserved for one month kept their cytotoxicity. In NSG mice with intraperitoneal SKOV3-Luc tumors, 6, 10 or 14 injections of 1 × 10^7 CAR cells extended median survival by 68%, 120% and 132% versus PBS. In HCT116-Luc mice, median survival rose from 39.5 to 57 days. Tumors regrew after treatment ended. Combining CAR cells with Zome…

Download Now →

Author: Wei Xia Ang, Yu Yang Ng +9 more

Publications VST Cells G-Rex®500M-CS

Publication Date: May 3, 2020

Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, Lentivirus Modified CD4 T Cells for HIV Functional Cure

A clinical-scale process was developed to make autologous CD4 T cells enriched for HIV Gag specificity and protected from HIV by the lentiviral vector AGT103, which targets CCR5 plus HIV Tat and Vif. In small-scale work, Gag peptide stimulation followed by depletion of CD8, CD56, CD19 and γδ cells raised Gag-specific CD4 T cells from 0.04% to 9.91%, with 4,607-fold expansion, and effector memory cells formed the main subset (80.28%). AGT103 cut CCR5 on JC53 cells by more than 98%. Running the process on a CliniMACS Prodigy with expansion in a G-Rex® 500M-CS vessel gave an average of 15.13% Gag-specific CD4 cells and 7 × 10^8 Gag-specific cells per product in large-scale runs with seven ad…

Download Now →

Author: Haishan Li, Tyler Lahusen +5 more

Publications NK Cells G-Rex®6 Well Plate

Publication Date: March 24, 2020

Inhibition of MICA and MICB Shedding Elicits NK cell–mediated Immunity against Tumors Resistant to Cytotoxic T cells

Blocking proteolytic shedding of MICA and MICB with a monoclonal antibody allowed NK cells to attack metastases that cytotoxic T cells cannot control. In mouse lung metastasis models with B16F10 and LLC1 cells expressing human MICA, the 7C6 antibody reduced metastases, including those formed by B2m-knockout or Jak1-knockout cells, and NK-cell depletion removed or reduced this benefit. The antibody was more effective against B2M-knockout than control human A375 melanoma cells in NK-cell killing assays. Combining the antibody with panobinostat (10 mg/kg) raised MICA/B surface levels and reduced lung metastases formed by control A375 cells in NSG mice given human NK cells. Antibody alone red…

Download Now →

Author: Lucas Ferrari de Andrade, Sushil Kumar +7 more